One morning sentence was too strong. Scale is still unconfirmed.

The afternoon did not strengthen the morning map; it corrected one part of it. Cheap-intercept capability is not merely hypothetical in U.S. procurement — a May 19 IDIQ already exists. The unresolved question is whether that vehicle converts into meaningful quantities and manufacturing scale.

The afternoon did not strengthen the morning map. It did, however, correct one part of it.

The most important development came from the hunt itself. One morning sentence was too strong.

Cheap-intercept capability is not merely hypothetical in U.S. procurement. A May 19 IDIQ already exists. The unresolved question is whether that vehicle converts into meaningful quantities and manufacturing scale.

The morning thesis map largely stands. This note does not rewrite it.

What changed since the morning

AI power — unchanged. Cooling (SLB–Kelvion, this morning) and switchgear (nVent–Maverick, August 24) remain announced, not closed. No new interconnection print.

Critical minerals — unchanged. Hemerdon offtake still unsigned. No new government package today.

RAS oncology — unchanged. One labeled use. Not a platform.

Defense / counter-autonomy — thesis corrected, scale still unconfirmed. This morning we wrote that cheap interceptors are not yet a U.S. purchase. That was wrong. On May 19 Perennial Autonomy announced a three-year indefinite-delivery contract with a $500 million ceiling, coordinated by Joint Interagency Task Force 401, covering Merops interceptors. Independent coverage the same day reports the same vehicle. Merops has been described at about $15,000 versus Shahed at about $30,000–$50,000. That is a U.S. cheap-intercept vehicle. It is not PAC-3. It is not THAAD. It is not this session’s award. A ceiling is not throughput. The live question is task orders and quantities versus the exquisite interceptor frameworks announced this morning.

Gold — consensus carry.

Consumer / distress — no promotion.

What should happen next

Disclosed IDIQ task orders or quantities on cheap intercept. Until then, scale is unconfirmed.

A named interconnection filing, a signed Hemerdon offtake, or a second RAS indication would be new evidence. They did not appear today.

What would invalidate

The cheap-intercept IDIQ produces no meaningful orders while PAC-3 and THAAD remain the only industrial print. Invalidation on the other morning themes is unchanged.